Bleakley Financial Group’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-22,325
Closed -$135K 945
2022
Q4
$135K Buy
+22,325
New +$135K ﹤0.01% 814